ORIGINALLY PUBLISHED IN DE MODE | WORLD
Article Published on: 10TH FEB 2025 | www.demodemagazine.com
Human Metapneumovirus (hMPV): An Overview
Human Metapneumovirus (hMPV) is a respiratory virus that belongs to the Paramyxoviridae family and primarily causes infections in the upper and lower respiratory tracts. First identified in 2001 in the Netherlands, hMPV has since been recognized as a significant contributor to respiratory illnesses worldwide. It is closely related to the respiratory syncytial virus (RSV) and can cause mild to severe illness, particularly in young children, older adults, and immunocompromised individuals.
Symptoms and Transmission
hMPV symptoms are similar to those of the flu and other respiratory infections. Common symptoms include cough, fever, nasal congestion, sore throat, and shortness of breath. In severe cases, it can lead to bronchitis or pneumonia, requiring hospitalization. The virus spreads through respiratory droplets when an infected person coughs or sneezes and can also be transmitted via direct contact with contaminated surfaces.
Diagnosis and Treatment
Diagnosis of hMPV is typically made using polymerase chain reaction (PCR) tests or antigen detection. Because symptoms overlap with other respiratory viruses, laboratory testing is essential for confirmation. There is no specific antiviral treatment for hMPV; management is mainly supportive, including hydration, fever reducers, and oxygen therapy in severe cases.
Prevention and Public Health Impact
Preventive measures include good hygiene practices such as handwashing, avoiding close contact with sick individuals, and disinfecting surfaces. Currently, no vaccine is available for hMPV, though research is ongoing. hMPV is a significant cause of respiratory illness globally, especially in vulnerable populations, highlighting the need for increased awareness and preventive strategies.